Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imaging

British Journal of Clinical Pharmacology

Volumn 64, Issue 5, 2007, Pages 580-590

  Van Der Schueren, B J ^a   De Hoon, J N ^a   Vanmolkot, F H ^a   Van Hecken, A ^a   Depre, M ^a   Kane, S A ^b   De Lepeleire, I ^b   Sinclair, S R ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Calcitonin gene related peptide; Capsaicin; Migraine therapy; Reproducibility; Vasodilation

Indexed keywords

CAPSAICIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING; HUMAN; LASER SOPPLER PERFUSION IMAGING; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SKIN; SKIN BLOOD FLOW; TREATMENT RESPONSE; VASODILATATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BLOOD FLOW VELOCITY; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FOREARM; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; PIPERAZINES; QUINAZOLINES; REPRODUCIBILITY OF RESULTS; SENSORY SYSTEM AGENTS; SKIN; TREATMENT OUTCOME;

EID: 35248901839     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02939.x     Document Type: Article

References (53)

1. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991 43 : 143 201.
2. Högyes A. Beiträge zur physiologischen Wirkung der Bestandteile des Capsicum annuum. Arch Exp Pathol Pharmakol 1878 9 : 117 30.
3. Porszasz J, Jancso N. Studies on the action potentials of sensory nerves in animals desensitized with capsaicine. Acta Physiol Acad Sci Hung 1959 16 : 299 306.
4. Szallasi A, Blumberg PM. Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor. Life Sci 1990 47 : 1399 408.
5. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997 389 (6653 816 24.
6. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999 51 : 159 212.
7. Nagy I, Rang H. Noxious heat activates all capsaicin-sensitive and also a sub-population of capsaicin-insensitive dorsal root ganglion neurons. Neuroscience 1999 88 : 995 7.
8. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998 21 : 531 43.
9. Trevisani M, Smart D, Gunthorpe MJ, Tognetto M, Barbieri M, Campi B, Amadesi S, Gray J, Jerman JC, Brough SJ, Owen D, Smith GD, Randall AD, Harrison S, Bianchi A, Davis JB, Geppetti P. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci 2002 5 : 546 51.
10. Helme RD, McKernan S. Neurogenic flare responses following topical application of capsaicin in humans. Ann Neurol 1985 18 : 505 9.
11. LaMotte RH, Shain CN, Simone DA, Tsai EF. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J Neurophysiol 1991 66 : 190 211.
12. LaMotte RH, Lundberg LE, Torebjork HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol 1992 448 : 749 64.
13. Sumikura H, Andersen OK, Drewes AM, Arendt-Nielsen L. Spatial and temporal profiles of flare and hyperalgesia after intradermal capsaicin. Pain 2003 105 : 285 91.
14. Hughes SR, Brain SD. A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin. Br J Pharmacol 1991 104 : 738 42.
15. Brain SD, Williams TJ. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol 1985 86 : 855 60.
16. Escott KJ, Connor HE, Brain SD, Beattie DT. The involvement of calcitonin gene-related peptide (CGRP) and substance P in feline pial artery diameter responses evoked by capsaicin. Neuropeptides 1995 29 : 129 35.
17. Petersen LJ, Winge K, Brodin E, Skov PS. No release of histamine and substance P in capsaicin-induced neurogenic inflammation in intact human skin in vivo: a microdialysis study. Clin Exp Allergy 1997 27 : 957 65.
18. Wallengren J. Vasoactive peptides in the skin. J Invest Dermatol Symp Proc 1997 2 : 49 55.
19. Tafler R, Herbert MK, Schmidt RF, Weis KH. Small reduction of capsaicin-induced neurogenic inflammation in human forearm skin by the glucocorticoid prednicarbate. Agents Actions 1993 38 : C31 4.
20. Huttunen M, Harvima IT, Ackermann L, Harvima RJ, Naukkarinen A, Horsmanheimo M. Neuropeptide- and capsaicin-induced histamine release in skin monitored with the microdialysis technique. Acta Derm Venereol 1996 76 : 205 9.
21. Herbert MK, Tafler R, Schmidt RF, Weis KH. Cyclooxygenase inhibitors acetylsalicylic acid and indomethacin do not affect capsaicin-induced neurogenic inflammation in human skin. Agents Actions 1993 38 : C25 7.
22. Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001 24 : 487 517.
23. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004 350 : 1104 10.
24. Fullerton A, Stucker M, Wilhelm KP, Wardell K, Anderson C, Fischer T, Nilsson GE, Serup J. Guidelines for visualization of cutaneous blood flow by laser Doppler perfusion imaging. A report from the Standardization Group of the European Society of Contact Dermatitis based upon the HIRELADO European community project. Contact Dermatitis 2002 46 : 129 40.
25. Del Bianco E, Geppetti P, Zippi P, Isolani D, Magini B, Cappugi P. The effects of repeated dermal application of capsaicin to the human skin on pain and vasodilatation induced by intradermal injection of acid and hypertonic solutions. Br J Clin Pharmacol 1996 41 : 1 6.
26. Hershey JC, Corcoran HA, Baskin EP, Salvatore CA, Mosser S, Williams TM, Koblan KS, Hargreaves RJ, Kane SA. Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay. Regul Pept 2005 127 : 71 7.
27. Sanchez MM, Binkowitz BS. Guidelines for measurement validation in clinical trial design. J Biopharm Stat 1999 9 : 417 38.
28. Bradley E, Blackwood L. Comparing Paired Data: a simultaneous test of means and variances. Am Stat 1981 43 : 234 35.
29. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 1991 12 (4 Suppl. 142S 158S.
30. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989 45 : 255 68.
31. Quiroz J. Assessment of equivalence using a concordance correlation coefficient in a repeated measurements design. J Biopharm Stat 2005 15 : 913 28.
32. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 1 (8476 307 10.
33. Bland JM, Altman DG. Measurement error. BMJ 1996 313 : 744.
34. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials 1990 11 : 116 28.
35. Schabauer AM, Rooke TW. Cutaneous laser Doppler flowmetry: applications and findings. Mayo Clin Proc 1994 69 : 564 74.
36. Kubli S, Waeber B, Dalle-Ave A, Feihl F. Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function. J Cardiovasc Pharmacol 2000 36 : 640 8.
37. Fullerton A, Rode B, Serup J. Studies of cutaneous blood flow of normal forearm skin and irritated forearm skin based on high-resolution laser Doppler perfusion imaging (HR-LDPI). Skin Res Technol 2002 8 : 32 40.
38. Docherty RJ, Yeats JC, Bevan S, Boddeke HW. Inhibition of calcineurin inhibits the desensitization of capsaicin-evoked currents in cultured dorsal root ganglion neurones from adult rats. Pflugers Arch 1996 431 : 828 37.
39. Liu L, Simon SA. Capsaicin-induced currents with distinct desensitization and Ca2+ dependence in rat trigeminal ganglion cells. J Neurophysiol 1996 75 : 1503 14.
40. Gazerani P, Andersen OK, Arendt-Nielsen L. A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences. Pain 2005 118 : 155 63.
41. Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995 38 : 1337 44.
42. Morris SJ, Shore AC. Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol 1996 496 : 531 42.
43. Veves A, Saouaf R, Donaghue VM, Mullooly CA, Kistler JA, Giurini JM, Horton ES, Fielding RA. Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes 1997 46 : 1846 52.
44. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990 300 : 230 5.
45. Vanmolkot FH, de Hoon JN. Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography. Br J Clin Pharmacol 2005 59 : 387 97.
46. Akerman S, Kaube H, Goadsby PJ. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. Br J Pharmacol 2003 140 : 718 24.
47. Newbold P, Brain SD. An investigation into the mechanism of capsaicin-induced oedema in rabbit skin. Br J Pharmacol 1995 114 : 570 7.
48. Moussaoui SM, Philippe L, Le Prado N, Garret C. Inhibition of neurogenic inflammation in the meninges by a non-peptide NK1 receptor antagonist, RP 67580. Eur J Pharmacol 1993 238 : 421 4.
49. Weidner C, Klede M, Rukwied R, Lischetzki G, Neisius U, Skov PS, Petersen LJ, Schmelz M. Acute effects of substance P and calcitonin gene-related peptide in human skin - a microdialysis study. J Invest Dermatol 2000 115 : 1015 20.
50. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 1979 310 : 175 83.
51. Hughes SR, Brain SD. Nitric oxide-dependent release of vasodilator quantities of calcitonin gene-related peptide from capsaicin-sensitive nerves in rabbit skin. Br J Pharmacol 1994 111 : 425 30.
52. Goldsmith PC, Leslie TA, Hayes NA, Levell NJ, Dowd PM, Foreman JC. Inhibitors of nitric oxide synthase in human skin. J Invest Dermatol 1996 106 : 113 8.
53. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med 2002 346 : 257 70.